Abiopharma

🔍 BOECKMANN ALAN L (Director)

Company: NUSCALE POWER Corp (SMR)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 3,470 shares of Phantom Stock (Derivative)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 3,470.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: Each share of phantom stock represents a right to receive one share of Class A Common stock on a one-for-one basis.
• F2: In lieu of quarterly cash fees, 3,470 shares of phantom stock were granted on March 31, 2026. Pursuant to the Company's Deferred Compensation Plan for Non-Employee Directors, the reporting person elected to defer settlement of the underlying shares of Class A Common Stock. The phantom stock becomes payable upon the reporting person's separation from service with the Company.